Advertisement
Home Tags Heartburn / GERD / Indigestion

Tag: Heartburn / GERD / Indigestion

Proton pump inhibitor use is associated with increased risk of developing osteoporosis and osteopenia in femur bones

PPI Use Ups Risk of Osteoporosis, Osteopenia in Femur

PPI users have reduced mean femoral T-scores, increased frequency of osteoporosis, osteopenia
Proton pump inhibitors increase the risk of nonsteroidal anti-inflammatory drug-induced small bowel injury

PPI Use Ups NSAID-Induced Small Bowel Injury

Increased risk of small bowel injury for healthy participants treated with celecoxib + PPI
Laparoscopic antireflux surgery and esomeprazole are both beneficial for patients with chronic gastroesophageal reflux disease

Laparoscopic Antireflux Sx May Provide Added Benefits in GERD

Lasting reduction in esophageal acid reflux with LARS and esomeprazole; greater reduction with LARS
For patients with gastroesophageal reflux disease

Lasting Safety, Efficacy for Magnetic Device in GERD

Lasting improvements in health-related QoL with magnetic sphincter augmentation device
Patients who regularly use proton pump inhibitors may be at increased risk of developing chronic kidney disease

Proton Pump Inhibitors Tied to Chronic Kidney Disease

Risk increased the longer people used the medications
Mortality and reoperation rates are very low among working-age patients with severe gastroesophageal reflux disease undergoing primary laparoscopic fundoplication

Mortality Low for Laparoscopic Surgery in Severe GERD

For patients with severe GERD, low rates of 90- and 30-day mortality and 90-day reoperation
For patients requiring dual antiplatelet therapy

ACC: PPI Tx Also Beneficial for Those on Low-Dose Aspirin

Gastroprotection with PPI therapy reduced primary GI end point in patients on low-dose aspirin
Use of proton pump inhibitors may be linked to long-term kidney damage

Proton Pump Inhibitors Linked to Chronic Kidney Disease

While study can't prove cause-and-effect, increasing damage seen as dose rises
CYP2C19 polymorphism impacts response to proton pump inhibitor treatment in gastroesophageal reflux disease

CYP2C19 Polymorphism Impacts Response to PPI Tx in GERD

Meta-analysis shows lower efficacy rates to proton pump inhibitors for rapid metabolizer genotype
Proton pump inhibitors appear to be linked with increased risk of chronic kidney disease

ASN: PPIs Linked to Higher Risk of Chronic Kidney Disease

But studies weren't designed to prove proton pump inhibitors are responsible for the increase